Drug intelligence / Profile preview

Bladder instillation without triamcinolone acetonide

Development stage
Unknown
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Intravesical
01

Overview

Bladder instillation without triamcinolone acetonide is a specific combination therapy administered directly into the bladder for treating interstitial cystitis/bladder pain syndrome (IC/BPS). The standard solution contains: - **Heparin**: A glycosaminoglycan that may help repair the bladder's protective lining - **Viscous lidocaine**: A local anesthetic that provides pain relief - **Sodium bicarbonate**: A buffering agent that helps optimize the pH of the solution - **Bupivacaine**: Another local anesthetic for pain management This formulation specifically excludes triamcinolone acetonide, which is sometimes included in other bladder instillation cocktails. This therapy is administered through catheterization, with the solution being held in the bladder for approximately 20-30 minutes. Clinical studies have shown that this instillation solution can improve symptoms associated with interstitial cystitis-bladder pain syndrome, as measured by a decrease in the O'Leary-Sant (OLS) questionnaire score. The treatment is typically administered as a series of instillations, with patients in clinical trials receiving six bladder instillations. According to the American Urological Association's clinical guidelines, bladder instillations are indicated as a treatment option when diet modification, stress management, and over-the-counter products are not sufficient for managing IC/BPS symptoms. For heparin specifically, when used as part of these instillations, a solution of 10,000 units diluted with saline solution is typically instilled daily and held in the bladder for 20-30 minutes. Patients can be taught to self-catheterize and administer treatments at home. After 3-4 months, the frequency may be reduced to 3-4 times per week.

Other names
Bladder instillation without triamcinolone acetonidestandard bladder instillationcontrol instillation solution
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Bladder instillation without triamcinolone acetonide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bladder instillation without triamcinolone acetonide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call